Adasuve: FDA Approves First Inhaled Treatment For Schizophrenia And Bipolar Disorder
Dec 21 (Reuters) - Alexza Pharmaceuticals Inc said the U.S. health regulators approved Adasuve, making it the first treatment
adasuve fda approve inhaled treatment schizophrenia bipolar disorder dec reuters alexza pharmaceuticals inc say  USA  health regulator approve adasuve make treatment